内分泌干扰剂对女性生育能力的影响:最新情况
Christian Tague1, Dujardin Makeda1, Hermann Yokolo1
1Department of Research, Medical Research Circle (MedReC), Goma, DR Congo.
Annals of medicine and surgery (2012)
|November 3, 2025
概括
内分泌干扰剂 (EDs) 是干扰激素的化学物质,可能损害女性生殖健康. 研究将ED与不孕症,卵巢问题以及生育治疗的较差结果联系在一起.
科学领域:
- 环境健康 环境健康
- 内分泌学 在内分泌学.
- 生殖生物学 生殖生物学
背景情况:
- 内分泌干扰剂 (EDs) 是日常产品中发现的多种化学物质,导致人类广泛暴露.
- 常见的ED包括双A,甲酸盐,帕拉,二氧化和农药,这些农药被认为会干扰荷尔蒙调节.
研究的目的:
- 审查内分泌干扰剂对女性生殖健康的影响.
- 探索EDS的作用机制和观察到的健康影响.
主要方法:
- 关于内分泌干扰剂和女性生殖的动物和人类研究的文献综述.
- 分析机制,包括激素受体相互作用,表观遗传变化和轴干扰.
主要成果:
- 脱发性疾病与卵巢储备减少,卵细胞成熟受损,排卵和植入发生改变有关.
- 观察到EDs与多囊卵巢综合征,子宫内膜异位症和辅助生殖技术成功率降低等疾病之间的联系.
结论:
- 关于EDs生殖效应的人类数据在很大程度上是观察性的,并面临诸如暴露评估变化和"尾酒效应"等局限性.
- 进一步的研究,加强预防和监管措施对于减轻女性生殖健康风险至关重要.
相关概念视频
Infertility in Females
3.6K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
3.6K
Oogenesis
68.9K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
68.9K
Infertility in Males
522
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
522
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Spermatogenesis
121.5K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
121.5K
Target Cell Response to Hormones
5.1K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.1K


